Biotech News Brief

Biotech news for Sunday, June 21, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.

Jun 17, 7:53 AM EDT

Dyne Therapeutics expands debt facility with Hercules Capital to $400M

DYN

Dyne Therapeutics ( DYN ) said it expanded its senior secured debt facility with Hercules Capital ( HTGC ) to up to $400M, adding $125M in new borrowing capacity. The amended non-dilutive financing agreement includes an immediate $50M funding at closing, a new…

Jun 17, 6:56 AM EDT

Altimmune shifts headquarters to New Jersey, targeting biopharma talent and cost savings

ALT

Philippe TURPIN/Photononstop via Getty Images Altimmune ( ALT ) said that it will relocate its headquarters from Gaithersburg, Maryland, to Morristown, New Jersey, later this year in a bid to attract biopharma talent and improve cost efficiencies. The company…

Jun 17, 3:19 AM EDT

Moderna eyes German production sites amid BioNTech plant closures - report

MRNABNTX

hapabapa U.S. vaccine maker Moderna ( MRNA ) is exploring investments in manufacturing facilities in Germany and is particularly interested in acquiring sites that rival BioNTech ( BNTX ) plans to shut down as part of its restructuring efforts, CEO Stephane